Biomea Fusion, Inc.(BMEA)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
BMEA Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Biomea Fusion, Inc. (BMEA), a Healthcare sector company. BMEA is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), Biomea Fusion, Inc. reports net income of $-12.4M, free cash flow of $-11.7M. Top institutional holders of BMEA by reported 13-F value include FMR, VANGUARD CAPITAL MANAGEMENT, Aisling Capital Management, based on the most recent SEC filings. BMEA trades on the Nasdaq exchange and files with the SEC under CIK 1840439. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BMEA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Biomea Fusion, Inc. directly from SEC EDGAR.
Net Income
Q1 2026
$-12.4M
Free Cash Flow
Q1 2026
$-11.7M
Get alerted when BMEA's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Biomea Fusion, Inc. including:
Top Institutional Holders of BMEA
FMR LLC
$13.5M8,813,359 shVANGUARD CAPITAL MANAGEMENT LLC
$4.0M2,597,300 shAisling Capital Management LP
$3.1M2,048,757 shRENAISSANCE TECHNOLOGIES LLC
$2.0M1,312,798 shMARSHALL WACE, LLP
$1.8M1,198,551 shCITADEL ADVISORS LLC
$1.0M656,817 shMariner, LLC
$1.0M654,578 shBlackRock, Inc.
$981.4K641,435 shSUSQUEHANNA INTERNATIONAL GROUP, LLP
$963.7K629,865 shFIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
$852.3K557,036 sh
| Fund | Value | Shares |
|---|---|---|
| FMR LLC | $13.5M | 8,813,359 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.0M | 2,597,300 |
| Aisling Capital Management LP | $3.1M | 2,048,757 |
| RENAISSANCE TECHNOLOGIES LLC | $2.0M | 1,312,798 |
| MARSHALL WACE, LLP | $1.8M | 1,198,551 |
| CITADEL ADVISORS LLC | $1.0M | 656,817 |
| Mariner, LLC | $1.0M | 654,578 |
| BlackRock, Inc. | $981.4K | 641,435 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $963.7K | 629,865 |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $852.3K | 557,036 |
More Healthcare Companies
View all Healthcare →Put BMEA on your watchlist
Track score changes the day Biomea Fusion, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BMEA a good stock to buy?
13F Pro's AI-powered analysis of Biomea Fusion, Inc. (BMEA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BMEA are available on the BMEA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own BMEA?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BMEA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Biomea Fusion, Inc.'s investment landscape.